The newly approved radiotracer is seen as a major step forward for nuclear imaging technology. Specialists have been looking forward to its arrival on the market for quite some time.

ShortCut, which gained the FDA’s breakthrough device designation back in January, is used to split valve leaflets and reduce the risk of obstruction.

“Unlike expensive pharmaceuticals like Ozempic, which require lifetime use, time-restricted eating is a simple lifestyle change that does not cause side effects and can be maintained indefinitely,” one doctor explained. 

According to Medtronic, its goal was to develop a user-friendly ECMO device that makes patient care as intuitive as possible.

The suit, which includes multiple accusations of malpractice and dishonest behavior, is just the latest chapter of a story that has been making headlines for years. 

Early data suggest the J-Valve transcatheter heart valve could help care teams avoid a rare, but often fatal TAVR complication when treating high-risk patients. 

Today's heart teams already face a number of challenges on a day-to-day basis.  New data suggest they could soon be treating more patients than ever before.  

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Heart teams already view reduced LVEF as a potential risk factor, but research into its long-term impact on patient outcomes has been limited. 

The new Cordella device from Endotronix, now an Edwards Lifesciences company, uses an implantable device to track the patient's pulmonary artery pressure and other helpful health data.